Marotta, C.; Cirri, D.; Kanavos, I.; Ronga, L.; Lobinski, R.; Funaioli, T.; Giacomelli, C.; Barresi, E.; Trincavelli, M.L.; Marzo, T.;
et al. Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth—An Investigation of the Activation Mechanism and Their Nanoformulation. Pharmaceutics 2024, 16, 278.
https://doi.org/10.3390/pharmaceutics16020278
AMA Style
Marotta C, Cirri D, Kanavos I, Ronga L, Lobinski R, Funaioli T, Giacomelli C, Barresi E, Trincavelli ML, Marzo T,
et al. Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth—An Investigation of the Activation Mechanism and Their Nanoformulation. Pharmaceutics. 2024; 16(2):278.
https://doi.org/10.3390/pharmaceutics16020278
Chicago/Turabian Style
Marotta, Carlo, Damiano Cirri, Ioannis Kanavos, Luisa Ronga, Ryszard Lobinski, Tiziana Funaioli, Chiara Giacomelli, Elisabetta Barresi, Maria Letizia Trincavelli, Tiziano Marzo,
and et al. 2024. "Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth—An Investigation of the Activation Mechanism and Their Nanoformulation" Pharmaceutics 16, no. 2: 278.
https://doi.org/10.3390/pharmaceutics16020278
APA Style
Marotta, C., Cirri, D., Kanavos, I., Ronga, L., Lobinski, R., Funaioli, T., Giacomelli, C., Barresi, E., Trincavelli, M. L., Marzo, T., & Pratesi, A.
(2024). Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth—An Investigation of the Activation Mechanism and Their Nanoformulation. Pharmaceutics, 16(2), 278.
https://doi.org/10.3390/pharmaceutics16020278
